Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial. - Thallinger, Christiane; Lang, Istvan; Kuhar, Cvetka Grasic; Bartsch, Rupert; Singer, Christian F; Petruzelka, Lubos; Melichar, Bohuslav; Knittelfelder, Regina; Brodowicz, Thomas; Zielinski, Christoph (BMC Cancer, 2016)